Valeant says wait one more year for turnaround; shares fall
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
Valeant Pharma (VRX) Setting Stage for Potential Capital Raise in 2018 - Evercore ISI's Raffat
February 28, 2018 9:50 AM ESTEvercore ISI analyst Umer Raffatt thinks Valeant Pharma (NYSE: VRX) could tap the capital market this year.
He notes while Valeant gave no clear answer on whether Valeant will look to raise capital near term and emphasized that there... More
